Johnson & Johnson
NYSE: JNJ
$166.10
-$1.60 (-1.0%)
Real Time Data Delayed 15 Min.
JNJ Articles
Achillion Pharmaceuticals saw its shares make a handy gain on Thursday after the company announced a secondary offering.
Published:
Last Updated:
These are four quality companies that should continue to do well in 2018. Investors to want to buy the shares and put them in their accounts for a long time.
Published:
24/7 Wall St. tracks key analyst calls in the stocks that move the markets and which are important to investors. It has been almost amazing to see just how many price targets have been raised for...
Published:
Last Updated:
UnitedHealth, J&J, Nike, and Verizon lifted the DJIA on Tuesday.
Published:
Last Updated:
Johnson & Johnson reported better-than-expected fiscal third-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
Earnings season is just kicking off for the third quarter with markets pushing all-time highs. Seven Dow stocks reporting this week, and nearly half of them are reporting on Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of GE, Verizon and other the Dow Jones Industrial Average companies scheduled to report their quarterly results this week.
Published:
Last Updated:
Walmart, Johnson & Johnson, McDonald's, and Visa pushed the DJIA higher on Wednesday.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday include AbbVie, Gilead, Johnson & Johnson, Potash, Schlumberger, Visa and Walmart.
Published:
Last Updated:
These five new additions to Deutsche Bank’s Conviction List all make good sense for growth portfolios now.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Monday include Ctrip.com, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan Stanley, Yelp and Yum China.
Published:
Last Updated:
U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. But this part of the market has not come without controversy in the past year and a half.
Published:
Last Updated:
24/7 Wall St. has collected several catalysts that are coming up in October for biotech and pharmaceutical companies.
Published:
The top analyst upgrades, downgrades and other research calls from Monday include Albermarle, Blue Apron, Box, Dish Network, GM, Transocean and Under Armour.
Published:
Last Updated:
Apple, P&G, Johnson & Johnson, and Verizon led the DJIA lower on Thursday.
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.